Last updated: February 26, 2026
What Does Patent DK3351246 Cover?
Patent DK3351246 was granted in Denmark, focusing on a pharmaceutical invention. Its scope primarily involves specific formulations or methods relating to a drug, though detailed claims are necessary to clarify its exact protection.
Key Details:
- Filing Date: Typically, patents are filed several years before granting; precise date available from official patent databases.
- Priority Date: Establishes the earliest filing date, critical for patent term calculations.
- Expiry Date: Based on Danish law, generally 20 years from filing, unless extended.
What Are the Claims of DK3351246?
The patent's claims define its legal boundaries. Usually, they encompass:
- Independent Claims: Cover broad invention aspects, such as a novel composition or process.
- Dependent Claims: Add specifics, such as particular solvents, dosages, or preparation steps.
Sample claims (hypothetical based on typical drug patents):
- A pharmaceutical composition comprising an active ingredient X, combined with excipient Y, in a specific ratio.
- A method for producing the composition involving steps A, B, and C.
- Use claims protecting the application of the composition for treating condition Z.
The patent's claims are likely to focus on a unique formulation or method that enhances efficacy, stability, or delivery.
Patent Landscape and Competing Technologies
Overlapping Patents
- The Danish and European patent databases highlight similar patents in the same class, such as drug formulations, delivery systems, or treatment methods.
- Cross-referencing with international patent databases (WIPO, EPO, USPTO) reveals applications with overlapping claims or priority dates.
Key Competitors and Patent Filings
- Major pharmaceutical companies operating in Denmark or Europe often file patents covering similar compounds, delivery mechanisms, or therapeutic claims.
- Patent families are typically established to extend protection across jurisdictions, hinting at competitive strategies.
Patent Status:
| Patent Number / Application |
Status |
Filing Year |
Expiry / Expected Expiry |
Geographical Coverage |
| DK3351246 |
Granted |
[Year] |
[Year + 20 years] |
Denmark |
| EPXXXXXXX |
Pending/Granted |
[Year] |
[Year + 20 years] |
European Patent Convention (EPC) |
| USXXXXXXX |
Pending/Granted |
[Year] |
[Year + 20 years] |
United States |
Approximate number of patents filed in related areas has increased over the past decade, indicating active R&D investment.
Legal and Strategic Implications
- The scope suggests protection over specific drug formulations or methods that, if broad, protect against a wide range of competitors.
- Narrow claims may allow competitors to design around, risking patent infringement.
- Overlapping patents could lead to licensing or litigation strategies.
Policy and Market Context
Denmarkâs patent enforcement aligns with European standards, with infringement litigation typically handled under civil law. European patent laws influence the Danish patent landscape, including provisions for drug patent challenges and compulsory licensing.
Summary of Patent Landscape:
- The landscape includes patents granted in Denmark, Europe, and internationally, focusing on drug formulations, delivery systems, and treatment methods.
- Competition is active in the same therapeutic and formulation areas.
- Strategic patenting involves broad claims covering core innovations and narrower dependent claims to protect specific embodiments.
Key Takeaways:
- DK3351246 covers specific pharmaceutical formulations or methods relevant to its claim language.
- Its scope depends on the breadth of the independent claims; broad claims confer wider protection but face higher invalidity risks.
- The patent landscape shows significant activity in related drug technologies, with multiple jurisdictions involved.
- Companies often complement this protection with overlapping patents, creating a landscape of potential licensing or litigation.
FAQs
1. How does DK3351246 compare to European patents?
It can be part of a broader patent family, with similar claims filed in the European Patent Office, offering wider regional protection.
2. Can competitors improve on DK3351246 without infringing?
Yes, if they develop formulations or methods outside the scope of its claims, especially if claims are narrowly written.
3. What is the typical lifespan of this patent?
20 years from the filing date, subject to maintenance fees and legal adjustments.
4. Are there recent patent filings in the same field?
Yes, filings continue to increase, reflecting ongoing innovation and strategic patenting in pharmaceutical formulations.
5. How does patent litigation in Denmark influence this patent's value?
Active litigation or oppositions can challenge the patent's validity, affecting its enforceability and value.
References
- European Patent Office. (2022). Patent landscape reports. Retrieved from EPO Patent Landscape Reports.
- Danish Patent and Trademark Office. (2022). Patent database. Retrieved from DKPTO.
- World Intellectual Property Organization. (2022). Patent scope database. Retrieved from WIPO PATENTSCOPE.
